1 2 3 4 5 6 7 8 9 10 11
далее 0, 160, 3136-3140. 10. Ahuja T.S., Boughton J., Weiss V./Late recurrence of lupus nephritis in a renal transplant recipient: response to mycophenolatemofetil//Am. J. Med. Sci., 2001, 322, 166-169. 11. Austin НА, BoumpasD.T.,Vaughan E.M., BalowJ.E./Predicting renal outcome in severe lupus nephritis: contributions of clinical and histologic data// Kidney Int., 1994, 45, 544-550. 12. Cortes-Hernandez J., Ordi-Rios J., Labrador М. et al./ Predictors of poor renal outcome in patients with lupus nephritis treated with combined pulses of cyclophosphamide and methylprednisolone//Lupus, 2003, 12, 287-296. 13. Moroni G., Ventura D., Riva P. et al./ Antiphospholipid antibodies are associated with an increased risk for chronic renal insufficiency in patients with lupus nephritis// Am.J. Kidney OS., 2004,43,28-36. 14. Appel G.B., Cohen D.J., Pirani C.L et al./ Long-term follow-up of lupus nephritis: a study based on the WHO classification//Am. J. Med., 1987, 83, 877-885. 15. Bono L, Cameron J.S., Hicks J.A./ The very long-term prognosis and complications of lupus nephritis and its treatment// Q J Med., 1999, 92, 211-218. 16. Соловьев С.К., Торгашина А.В./Лечение волчаночного нефрита (обзор литературы)/ Русский медицинский журнал, 2005, 24 (248), 1163-1167, 17.ContrerasG., PardoV., Leclercq B. etal./Sequential therapies for proliferative lupus nephritis// N EngI J Med., 2004, 350, 971 -980. 18. D'Cruz D., Cuadrado M.J., Mujic F. et al./ Immunosupressive therapy in lupus nephritis// Clin. Exp. Rheum., 1997, 15,275-282. 19. Houssiau F.A./ Managemant of lupus nephritis: an update// J Am. Soc. Nephrol., 2004, 15, 2694-2704. 20. Chan T.M., U F.K., Tang C.S. et al/ Efficacy of mycophenolate mofetil in patients wnMiffuse proliferative lupus nephritis/ N.Engl. J. Med., 2000, 343, 1156-1162. •21. Chan T.M./ Lupus nephritis: induction therapy// Lupus, 2005, 14, 27-32.^ :. 22. Donadio J.V„ Holley K.E., Ferguson R.H., llstrup D.M./ Treatment of diffuse proliferative lupus nephritis with prednisone and combined prednisone and cyclophosphamide//N EngI. J. Med., 1978, 299, 1151-1155. 23. Steinberg A.D., Steinberg S.C./ Long-term preservation of renal function in patients with lupus nephritis receiving treatment that include cyclophosphamide versus those treated with prednisone only//Arthr. Rheum., 1991, 34, 945-950. 24. Gourley M.F., Austin НА, Scott D. et al./ Methylprednisolone and cyclophosphamide, alone or in combination , in patients with lupus nephritis. A randomized, controlled trial// Ann Intern Med., 1996, 125,549-557. 25. Boumpas D.T., Austin HA, Vaughn E.M. et al./ Controlled trial of pulse methylprednisolone versus two regimens of pulse CYC in severe lupus nephritis// Lancet, 1992, 340, 741-745. 26. Houssiau F.A., Vasconcelos С., D'Cruz D. et al./ Immunosuppressive therapy in lupus nephritis. The Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide//Arthr. Rheum., 2002, 46, 2121-2131. 27. Chan T.M., Cheng J.K.P. далее ...